seWhat is ?

(known chemically as or Lysyl-Prolyl-Valine) is a potent, naturally occurring tripeptide corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH) via the MC3 Receptor. Originally studied as an evolutionary derivative of larger proopiomelanocortin (POMC) peptides, researchers investigate for its isolated, highly targeted anti-inflammatory and antimicrobial properties. Unlike full-length melanocortin peptides, exerts its biological effects independently of pigment-producing MC1R activation, making it a primary subject for gastrointestinal mucosal repair and mast cell stabilization research.

For laboratory and in vitro evaluation, researchers often choose to buy in high-purity lyophilized form. reconstitution solution can be used to prepare specialized laboratory vectors to ensure baseline peptide distribution and prevent premature degradation during cellular screening assays.

Chemical and Molecular Data

What are the Mechanisms of Action?

The biochemical pathways and cellular targets of include:

• NF-κB Pathway Inhibition: Research demonstrates that translocates directly into the cytoplasm of target inflammatory cells, where it blocks the activation and nuclear migration of Nuclear Factor Kappa B (NF-κB). This inhibition downregulates the transcription of major pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6.
• Mast Cell Stabilization: In addition to systemic cytokine control, experimental observations note that acts directly on localized mast cell boundaries to inhibit degranulation cascades, subsequently decreasing histamine and leukotriene release during induced allergic or inflammatory events.
• Intestinal Epithelial Transport & Barrier Maintenance: Studies indicate that utilizes the PepT1 transporter system to enter intestinal epithelial cells. Once inside, it actively mitigates mucosal lining collapse, counteracting the structural structural breakdown observed in standard colitis and inflammatory bowel models.

What are the Clinical & Preclinical Trials on ?

When evaluating research efficacy and published experimental literature for :

• Gastrointestinal Mucosal In Vivo Assays: Investigations published across prominent gastroenterology literature evaluated administration within dextran sulfate sodium (DSS)-induced colitis models. The data demonstrated that oral or systemic introduction of the tripeptide significantly reduced histologic tissue damage, accelerated mucosal healing, and normalized local myeloperoxidase activity.
• Dermatological and Wound Healing Models: Preclinical evaluations focused on cutaneous inflammation established that topical applications of efficiently limit the severity of psoriasis-like skin presentations, dampening immune cell infiltration without generating systemic corticosteroid-like toxicity.
• Safety & Cellular Toxicity Screening: Across diverse laboratory evaluations, showcased an exemplary safety profile. Because it bypasses traditional melanocortin receptor pigment cascades, it demonstrates no impact on melanin production or baseline blood pressure metrics even at elevated research concentrations.

How does compare to other compounds?

To evaluate target specificity and tissue healing kinetics, researchers compare against larger systemic healing peptides and evaluate its contributions to advanced therapeutic blends:

Contributions to Advanced Peptide Matrices: operates via distinct immune-modulating pathways. In the specialized blend, works alongside systemic tissue regulators to create an optimal cellular environment for gastrointestinal restoration. When integrated into the + protocol, it delivers a dual-action mechanism where handles extracellular matrix remodeling and collagen synthesis, while rapidly shuts down localized mast cell reactivity and acute inflammatory pathways, optimizing tissue repair speeds.